“If you want to find the secrets of the universe, think in terms of energy, frequency and vibration.” 

Nikola Tesla

"Cymatrax is poised to revolutionize the experience of Sound, the building blocks of the Universe".

Rose Reveley CH., RYT

"Upon meeting with Cymatrax CEO Alan Brunton, and hearing all about the Cymatrax software, I am amazed at the possibilities and potential applications of this product. It’s unlike any software I’ve seen to date! Cymatrax has blended holistic healthcare and science through the application of sound and music, with the ability to create an enriched environment for the workplace and the home. To say the least this is a major breakthrough for the workplace in reducing stress and therefore significantly increasing productivity, a no-brainer for corporate America and small business alike. I can only imagine the possibilities for the home environment, such as stress and conflict reduction creating the potential for a more loving and supportive atmosphere. I think we all could use that. I know as soon as it’s available it will be in my office and home.Many thanks to you Mr. Brunton for making this a reality!"
Dr. Paul Hubbert, Ph.D.
Institute for Holographic Sound & Inner Balance
Austin, TX

Founding Grammy Hall of Fame member, Sir Earl Toon (Kool and the Gang) had this to say about Cymatrax: "The first one (a side by side blind comparison of his latest recording and the same treated with the Cymatrax software) was SWEET. I could hear each and every note. It was pinpoint precise. I had so much energy, I felt like I could dance all night. The second one (his own mastered recording) was murky. I felt like I wanted to roll up in a ball and go to sleep." When told the second recording listened to was his own, he responded "THIS SOFTWARE NEEDS TO GET TO EVERY RECORDING STUDIO IN THE COUNTRY, IN THE WORLD!"

Patricia Evans MD, PhD
UT Southwestern School MedicineResidency Director of Neurodevelopmental Disabilities

University of Texas Southwestern School of Medicine

Dr Evans has offered to oversee the clinical trials for Cymatrax.